Since some adverse effects such as serious infections and skin cancers were reported, additional evaluation of the safety profile of this drug is needed (Gordon 2012
Because coinsurance amounts are pegged to the list price, Medicare beneficiaries required to pay coinsurance could face monthly costs of $325 to $430 before they reach the new cap on annual out-of-pocket drug spending established by the Inflation Reduction Act around $3,300 in 2024, based on brand drugs only, and $2,000 in 2025
Melatonin suppresses ferroptosis induced by high glucose via activation of the Nrf2/HO-1 signaling pathway in type 2 diabetic osteoporosis
Endocrine Society Clinical Practice Guideline on Pharmacological Management of Obesity, 2024 Update
The glucagon component of retatrutide adds GI side effects that some patients cant manage even with slow titration
Most likely, the main risk is reduced effectiveness rather than immediate harm